Propofol: Nursing Drug Guide, Respiratory Depression & IV Safety

Propofol is marketed as DIPRIVAN (propofol injectable emulsion). Label-supported vial presentations are 20 mL, 50 mL, and 100 mL single-dose vials at 10 mg/mL.

• Lipid emulsion intended for intravenous use only.
• Strictly single-use: do not access a vial more than once.
• Once opened, complete administration within 12 hours.

Propofol supports induction and maintenance of general anesthesia, monitored anesthesia care (MAC) sedation in appropriate adults, and ICU sedation of intubated, mechanically ventilated adults. If concurrent analgesics or sedatives are ordered, verify interaction burden and cumulative depression risk during IV medication administration.

Propofol enhances inhibitory neurotransmission through positive modulation of GABA-A receptor activity, producing rapid hypnosis and sedation. Co-administration with CNS depressants such as midazolam can amplify respiratory and hemodynamic suppression. When neuromuscular blockade is planned, coordinate with teams using agents such as succinylcholine and ensure atropine or glycopyrrolate is available when vagal bradycardia is anticipated.

↔On a small screen, swipe or scroll sideways to see the full table.

Additional label dosing points

• Cardiac anesthesia induction: 0.5 to 1.5 mg/kg.
• Neurosurgical induction: 1 to 2 mg/kg.
• Pediatric induction age 3 to 16 years: 2.5 to 3.5 mg/kg.
• MAC initiation: 100 to 150 mcg/kg/min for 3 to 5 minutes or 0.5 mg/kg over 3 to 5 minutes; maintenance 25 to 75 mcg/kg/min.
• ICU sedation start: 5 mcg/kg/min for at least 5 minutes, then increase by 5 to 10 mcg/kg/min every 5 to 10 minutes.

Pretreatment checks

• Confirm airway equipment, oxygen, suction, and skilled support are immediately available
• Review concurrent opioids, benzodiazepines, and inhalational agents during medication reconciliation
• Verify egg or soybean allergy history and propofol hypersensitivity before opening vial
• Inspect emulsion for separation, large droplets, or discoloration—shake well and reject compromised product

Contraindications

• Known hypersensitivity to propofol or formulation components
• History of anaphylaxis to eggs, egg products, soybeans, or soy products

Important interactions

↔On a small screen, swipe or scroll sideways to see the full table.

Use controlled infusion delivery with independent checks and clear endpoint targets. Treat propofol as a high-alert medication workflow. Pair sedation titration with continuous capnography monitoring and pulse oximetry, and set pump guardrails during IV infusion pump setup.

• Assess airway, baseline blood pressure, and ventilation support readiness before each dose change.
• Keep immediate rescue medications and equipment available for protocolized bradycardia and airway pathways.
• When rapid sequence plans are active, verify paralytic backup availability per airway team plan.

Use strict aseptic technique with every spike, line entry, and syringe transfer. Propofol vials are single-dose only and must not be reused for another patient or later administration window.

↔On a small screen, swipe or scroll sideways to see the full table.

When discomfort at injection site is expected, dose-limit pretreatment with lidocaine according to the label cap.

• Target sedation reached without loss of ventilatory safety margin.
• Hemodynamics remain acceptable for the patient context and goals.
• No progressive metabolic pattern suggesting infusion toxicity.
• Documentation links sedation target, dose changes, and observed response.

• Respiratory depression including apnea, worsening difficulty breathing, and excessive sleepiness.
• Hypotension and reduced tissue perfusion during bolus or aggressive up-titration.
• Injection-site pain.
• Hypertriglyceridemia and metabolic disturbances with prolonged infusion.
• Hypersensitivity reactions in contraindicated patients, including risk of anaphylaxis.

• Rising ETCO2 with falling oxygen saturation despite support.
• Persistent MAP decline despite fluid resuscitation.
• Increasing lactate and worsening acidosis suggestive of PRIS.
• Rising triglycerides, hyperkalemia, or new ECG instability during prolonged infusion.
• Decreasing urine output with concern for evolving acute kidney injury.

Propofol overdose causes cardiorespiratory depression. There is no specific reversal antidote.

1. Stop propofol immediately.
2. Secure oxygenation and ventilation, including readiness for bag-valve-mask ventilation.
3. Support circulation with fluids, pressors, and anticholinergics according to clinical response and protocol.

• Elderly, debilitated, and ASA III-IV patients require lower induction and maintenance dosing.
• Patients on prolonged ICU infusion with severe infection, neurologic injury, or vasoactive support have higher PRIS vulnerability.
• Pediatric ICU sedation is not indicated; pediatric MAC sedation is not recommended.

Track cardiorespiratory status continuously and trend labs when infusion extends beyond brief procedural sedation. Use a structured ICU sedation pathway with predefined escalation triggers and direct handoff to teams covering mechanical ventilation monitoring.

↔On a small screen, swipe or scroll sideways to see the full table.

For prolonged infusions, trend basic metabolic panel components and document when adverse trends cross predefined escalation thresholds.

• Explain that propofol sedation is tightly monitored because breathing and blood pressure can change quickly.
• Review why staff may reduce or pause infusion when safety signals appear.
• Reinforce that post-sedation fatigue and confusion need monitoring before discharge transitions.
• Use clear medication handoff language when sedation agents are changed.

Propofol is often prepared near multiple sedatives and analgesics. Prevent look-alike and syringe-swap errors with independent double-checks and infusion labeling at the bedside.

• Read-back concentration and dose unit before starting or changing rate.
• Separate propofol syringes from benzodiazepine and opioid syringes physically and by label color.
• Confirm route and intended use during each handoff and pump change.

Practical shift reminders

• Reassess sedation depth and airway after each dose adjustment.
• Escalate early when trend clusters suggest PRIS rather than waiting for single critical values.
• Use standardized high-risk workflows for every handoff.

• Current or developing respiratory compromise not supported by immediate ventilatory plan.
• Progressive hypotension despite corrective measures.
• Infusion trending above 4 mg/kg/hour without explicit documented benefit-risk decision.
• Unresolved contraindication history (propofol, egg, or soybean hypersensitivity).
• Asepsis breach, uncertain vial open time, or unclear prep concentration.

Practice NCLEX-style clinical judgment practice for propofol using a tabbed case panel (MAR, labs, vitals, nursing notes), then rotate priority action, SATA cue recognition, trend interpretation, matrix urgency sorting, and documentation cloze—recognise cues → analyse → prioritise → act → evaluate outcomes when PRIS or apnea patterns persist despite intervention.

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

• Editorial Policy
• Medical Review Process
• Disclaimer

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.